RLMDRelmada Therapeutics, Inc.
$3.27+53% 1Y
$3.27
$2.1052 weeks$7.86
Is the price fair?
What RLMD's price assumes
- Price / book
- 3.76
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 3.76
- Market capitalisation106.7 million shares, counted Aug 4, 2026
- $349M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.